BOSTON SCIENTIFIC CORP (BSX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BSX currently has 1.48B outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 0.83% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 03, 2025 |
10-Q filing | 1481.7M shares outstanding |
1.5B | 0 |
| May 01, 2025 |
10-Q filing | 1477.2M shares outstanding |
1.5B | 0 |
| Feb 18, 2025 |
10-K filing | 1471.5M shares outstanding |
1.5B | 0 |
| Nov 01, 2024 |
10-Q filing | 1472.7M shares outstanding |
1.5B | 0 |
| Aug 01, 2024 |
10-Q filing | 1470.6M shares outstanding |
1.5B | 0 |
| May 01, 2024 |
10-Q filing | 1468.4M shares outstanding |
1.5B | 0 |
| Feb 20, 2024 |
10-K filing | 1463.5M shares outstanding |
1.5B | 0 |
| Nov 01, 2023 |
10-Q filing | 1464.5M shares outstanding |
1.5B | 0 |
| Aug 03, 2023 |
10-Q filing | 1456.2M shares outstanding |
1.5B | 0 |
| Jun 06, 2023 |
8-K filing: All outstanding shares of Boston Scientific Corporation's 5.50% Mandatory Convertible Preferred Stock, Series A, were automatically converted into approximately 24 million shares of Common Stock on June 1, 2023. |
1.4B | 0 |
| May 04, 2023 |
10-Q filing | 1435.8M shares outstanding |
1.4B | 0 |
| Feb 23, 2023 |
10-K filing | 1430.5M shares outstanding |
1.4B | 0 |
| Nov 03, 2022 |
10-Q filing | 1431.6M shares outstanding |
1.4B | 0 |
| Aug 04, 2022 |
10-Q filing | 1429.7M shares outstanding |
1.4B | 0 |
| May 05, 2022 |
10-Q filing | 1427.8M shares outstanding |
1.4B | 0 |
| Feb 23, 2022 |
10-K filing | 1422.3M shares outstanding |
1.4B | 0 |
| Nov 04, 2021 |
10-Q filing | 1423.8M shares outstanding |
1.4B | 0 |
| Aug 06, 2021 |
10-Q filing | 1421.3M shares outstanding |
1.4B | 0 |
| May 06, 2021 |
10-Q filing | 1418.7M shares outstanding |
1.4B | 0 |
| Feb 23, 2021 |
10-K filing | 1416.7M shares outstanding |
1.4B | 0 |
| Dec 14, 2020 |
8-K filing: Boston Scientific Corporation authorized a new stock repurchase program for up to $1.0 billion of common stock and repurchased 15.7 million shares at a weighted average price of $33.98, totaling $535 million, completing the prior authorization. ($535.0M proceeds) |
1.4B | 0 |
| Nov 05, 2020 |
10-Q filing | 1430.9M shares outstanding |
1.4B | 0 |
| Aug 05, 2020 |
10-Q filing | 1410.9M shares outstanding |
1.4B | 0 |
| May 28, 2020 |
8-K filing: Boston Scientific Corporation completed a public offering of 29,382,500 shares of common stock at $34.25 per share and 10,062,500 shares of 5.50% Mandatory Convertible Preferred Stock at $100.00 per share, resulting in net proceeds of approximately $1,949.3 million which was used to repay debt and for general corporate purposes. |
1.4B | 0 |
| May 22, 2020 |
8-K filing: Boston Scientific Corporation announced the pricing of a public offering of 25,550,000 shares of its common stock and 8,750,000 shares of its 5.50% Mandatory Convertible Preferred Stock, Series A. |
1.4B | 0 |
| May 06, 2020 |
10-Q filing | 1397.4M shares outstanding |
1.4B | 0 |
| Feb 25, 2020 |
10-K filing | 1391.5M shares outstanding |
1.4B | 0 |